Hu Che-Yuan, Wang Yu-An, Liao Kai-Wei, Wu Hung-Tsung, Ou Chien-Hui, Tan Choon Hui, Lee Wei-Ju
Department of Urology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 701, Taiwan.
Master Program in Food Safety, College of Nutrition, Taipei Medical University, Taipei 110, Taiwan.
Cancers (Basel). 2024 Sep 27;16(19):3313. doi: 10.3390/cancers16193313.
3-Monochloro-propanediol esters (3-MCPDEs), commonly found in refined edible oils and related products, have generated concerns due to their nephrotoxicity and carcinogenicity, yet clinical evidence remains limited.
In this study, we aimed to assess, for the first time, the accumulation of 3-MCPDEs in human kidney tissues, focusing on 68 participants, some with and others without renal cell carcinoma (RCC).
An analytical method for 3-MCPDE determination in kidney tissues underwent partial validation to ensure its suitability for sample analysis. The analyst was blind to the sample groups.
Results revealed significantly higher 3-MCPDE levels in RCC patients compared to non-RCC counterparts (0.22 vs. 0.01 µg/g) ( < 0.01). Moreover, no significant correlation was found between 3-MCPDE levels and tumor stage or size in the RCC group.
Accumulation of 3-MCPDEs in humans, with significantly higher levels was observed in kidney tumor specimens compared to non-patients. These findings suggest minimizing the intake of 3-MCPD and its esters in diets in order to reduce potential negative health impacts.
3-氯-1,2-丙二醇酯(3-MCPDEs)常见于精炼食用油及相关产品中,因其具有肾毒性和致癌性而引发关注,但临床证据仍然有限。
在本研究中,我们旨在首次评估68名参与者(部分患有肾细胞癌,部分未患)肾脏组织中3-MCPDEs的蓄积情况,重点关注患有和未患有肾细胞癌(RCC)的参与者。
对肾脏组织中3-MCPDEs的分析方法进行了部分验证,以确保其适用于样本分析。分析人员对样本分组情况不知情。
结果显示,与未患肾细胞癌的参与者相比,肾细胞癌患者的3-MCPDE水平显著更高(0.22 vs. 0.01 µg/g)(P < 0.01)。此外,在肾细胞癌组中,未发现3-MCPDE水平与肿瘤分期或大小之间存在显著相关性。
在人体中观察到3-MCPDEs的蓄积,与未患肾细胞癌的参与者相比,肾肿瘤标本中的3-MCPDE水平显著更高。这些发现表明应尽量减少饮食中3-氯-1,2-丙二醇及其酯类的摄入量,以降低潜在的健康负面影响。